The global infection control market is estimated to grow at a CAGR of 6.5% from 2016 to 2021 to reach USD 17.78 Billion

1. Infection Control Market worth 17.78 Billion USD by 2021. Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience.

2. The report "Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Browse 339 market data tables and 42 figures spread through 335 pages and in-depth TOC on “Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021” http://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html Early buyers will receive 10% customization on reports. This report studied the global infection control market during the forecast period of 2016 to 2021. The global infection control market is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 17.78 Billion by 2021. Growth in this market is attributed to factors such as rising incidence of hospital acquired infections (HAIs), growth in the number of surgical procedures, aging population, and rising focus on the need of food sterilization and disinfection. The global infection control market is segmented by product type, end users, and geography. This report also discusses the key drivers, restraints, opportunities, and challenges for this market. On the basis of product type, the market is primarily segmented into disinfection products and sterilization products. The disinfection products market is further sub-segmented into disinfectors, endoscopic reprocessors, disinfectants, and medical non-wovens. The market on sterilization products is further sub-segmented into sterilization method and contract sterilization. On the basis of end users, the market is categorized into hospitals, lifesciences companies, food industry, medical device companies, pharmaceutical companies, and other end users. In 2015, the disinfection products accounted for the largest share of the infection control market. This is majorly attributed to the large-scale use of disinfectors and medical nonwovens in the healthcare industry. However, the sterilization products market is expected to grow at a higher CAGR during the forecast period due to growing emphasis on infection control policies within hospital premises and strengthening of government regulations for quality of healthcare services. On the basis of region, the infection control market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Rise in pandemic diseases such as H1N1 flu, bird flu, natural disasters, and rising aging population with the resultant increase in the number of chronic disease cases, along with rise in nosocomial infections and surgical site infections have boosted the growth of the infection control markets in North America and Europe. However, Asia-Pacific region is expected to grow at the highest CAGR, owing to rising incidences of HAIs and increasing medical tourism in emerging countries such as China and India. Some of the major players operating in the global infection control market include STERIS Corporation (U.S.), 3M Company (U.S.), Belimed AG (Switzerland), Halyard Health, Inc. (U.S.), Sterigenics International, Inc. (U.S.), Getinge Group (Sweden), Advanced Sterilization Products (U.S.), MMM Group (Germany), Cantel Medical Corporation (U.S.), and Matachana Group (Spain). About MarketsandMarkets MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is

3. catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com